Wenshe Sun

854 total citations
21 papers, 689 citations indexed

About

Wenshe Sun is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Wenshe Sun has authored 21 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 8 papers in Molecular Biology and 6 papers in Materials Chemistry. Recurrent topics in Wenshe Sun's work include Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (4 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Wenshe Sun is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Nanoparticle-Based Drug Delivery (4 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Wenshe Sun collaborates with scholars based in China, United States and United Kingdom. Wenshe Sun's co-authors include Chunfu Zhang, Jingxing Yang, Mengfei Hou, Liqin Xiong, Yimin Chai, Qinghe Wu, Huilan Su, Shaowei Xie, Xiaowen Liang and Xuesong Liu and has published in prestigious journals such as ACS Nano, Advanced Functional Materials and Oncogene.

In The Last Decade

Wenshe Sun

21 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenshe Sun China 12 413 235 178 175 138 21 689
Hongjun Yuan China 15 365 0.9× 220 0.9× 171 1.0× 128 0.7× 117 0.8× 34 818
Xiaoyi Yin China 12 384 0.9× 191 0.8× 122 0.7× 135 0.8× 190 1.4× 33 683
Yikai Xu China 14 527 1.3× 269 1.1× 263 1.5× 221 1.3× 161 1.2× 24 804
Zhongqian Hu China 17 494 1.2× 294 1.3× 164 0.9× 99 0.6× 142 1.0× 31 839
Ningyue Yu China 16 536 1.3× 165 0.7× 137 0.8× 104 0.6× 193 1.4× 29 661
Jingyu Sun United States 12 457 1.1× 234 1.0× 258 1.4× 93 0.5× 140 1.0× 23 722
Danli Sheng China 12 833 2.0× 236 1.0× 252 1.4× 219 1.3× 264 1.9× 24 1.0k
Xiaoya Zhao China 15 298 0.7× 350 1.5× 135 0.8× 113 0.6× 111 0.8× 33 763
Di Jing China 14 332 0.8× 319 1.4× 109 0.6× 149 0.9× 270 2.0× 35 780
Ali Tarighatnia Iran 11 298 0.7× 153 0.7× 89 0.5× 111 0.6× 152 1.1× 32 576

Countries citing papers authored by Wenshe Sun

Since Specialization
Citations

This map shows the geographic impact of Wenshe Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenshe Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenshe Sun more than expected).

Fields of papers citing papers by Wenshe Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenshe Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenshe Sun. The network helps show where Wenshe Sun may publish in the future.

Co-authorship network of co-authors of Wenshe Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Wenshe Sun. A scholar is included among the top collaborators of Wenshe Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenshe Sun. Wenshe Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Wenshe, Shaowei Xie, Shi Liu, Xiaokun Hu, & Dongming Xing. (2024). Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy. International Journal of Nanomedicine. Volume 19. 3919–3942. 6 indexed citations
2.
Liu, Shifeng, et al.. (2024). Shining a light on liver health: advancements in fluorescence-enhanced enzyme biosensors for early disease detection. Frontiers in Bioengineering and Biotechnology. 12. 1392857–1392857. 1 indexed citations
3.
Du, Xinxing, Jiayi Wang, Jiazhou Liu, et al.. (2024). Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study. International Journal of Surgery. 110(3). 1450–1462. 4 indexed citations
4.
Liu, Shi, et al.. (2024). Breaking the barrier: Nanoparticle-enhanced radiotherapy as the new vanguard in brain tumor treatment. Frontiers in Pharmacology. 15. 1394816–1394816. 11 indexed citations
5.
Liu, Xinlin, Junwen Deng, Yang Yuan, et al.. (2023). Corrigendum to “Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer” [Pharmacology & Therapeutics 239 (2022) 108296]. Pharmacology & Therapeutics. 243. 108336–108336. 1 indexed citations
6.
Hou, Mengfei, Haiyang Su, Qinghe Wu, et al.. (2023). A Self‐Enhancing Nanoreactor Reinforces Radioimmunotherapy by Reprogramming Nutrients and Redox Metabolisms. Advanced Functional Materials. 33(16). 36 indexed citations
7.
Xie, Shaowei, Jiayi Wang, Yicheng Zhu, et al.. (2023). Engineering the MoS2/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens. Advanced Science. 10(15). e2206494–e2206494. 20 indexed citations
8.
Sun, Wenshe, et al.. (2023). Nanotechnology for brain tumor imaging and therapy based on π-conjugated materials: state-of-the-art advances and prospects. Frontiers in Chemistry. 11. 1301496–1301496. 1 indexed citations
9.
Liang, Bing, Chao Wang, Wenshe Sun, et al.. (2022). New insights into bacterial mechanisms and potential intestinal epithelial cell therapeutic targets of inflammatory bowel disease. Frontiers in Microbiology. 13. 1065608–1065608. 8 indexed citations
10.
Liu, Xinlin, Junwen Deng, Yang Yuan, et al.. (2022). Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer. Pharmacology & Therapeutics. 239. 108296–108296. 68 indexed citations
11.
Li, Mengjiao, Wenshe Sun, Yang Yuan, et al.. (2022). Breviscapine remodels myocardial glucose and lipid metabolism by regulating serotonin to alleviate doxorubicin-induced cardiotoxicity. Frontiers in Pharmacology. 13. 930835–930835. 17 indexed citations
12.
Lu, Qi, et al.. (2022). Liquiritigenin reverses skin aging by inhibiting UV‐induced mitochondrial uncoupling and excessive energy consumption. Journal of Cosmetic Dermatology. 22(3). 1017–1030. 6 indexed citations
13.
Sun, Wenshe, Jingxing Yang, Mengfei Hou, et al.. (2021). A Nano “Immune‐Guide” Recruiting Lymphocytes and Modulating the Ratio of Macrophages from Different Origins to Enhance Cancer Immunotherapy. Advanced Functional Materials. 31(23). 34 indexed citations
14.
Xie, Shaowei, Wenshe Sun, Chunfu Zhang, et al.. (2021). Metabolic Control by Heat Stress Determining Cell Fate to Ferroptosis for Effective Cancer Therapy. ACS Nano. 15(4). 7179–7194. 135 indexed citations
15.
Yao, Liangfang, Xuan Yang, Haiyang Zhang, et al.. (2020). Reciprocal REGγ-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma. Oncogene. 40(3). 677–692. 14 indexed citations
16.
Yang, Jingxing, Mengfei Hou, Wenshe Sun, et al.. (2020). Sequential PDT and PTT Using Dual‐Modal Single‐Walled Carbon Nanohorns Synergistically Promote Systemic Immune Responses against Tumor Metastasis and Relapse. Advanced Science. 7(16). 2001088–2001088. 161 indexed citations
17.
Yang, Chengcheng, Huilan Su, Jingxing Yang, et al.. (2019). GE11-PDA-Pt@USPIOs nano-formulation for relief of tumor hypoxia and MRI/PAI-guided tumor radio-chemotherapy. Biomaterials Science. 7(5). 2076–2090. 34 indexed citations
18.
Yang, Jingxing, Huilan Su, Wenshe Sun, et al.. (2018). Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases. Theranostics. 8(7). 1966–1984. 77 indexed citations
19.
Cai, Jiali, Huilan Su, Jingxing Yang, et al.. (2017). Feasibility of USPIOs for T1-weighted MR molecular imaging of tumor receptors. RSC Advances. 7(50). 31671–31681. 6 indexed citations
20.
Ali, Amjad, Wenshe Sun, Xiaona Lin, et al.. (2015). KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression. Cell Death and Disease. 6(3). e1681–e1681. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongjun Yuan Breakdown of academic impact, for papers by Xiaoyi Yin Breakdown of academic impact, for papers by Yikai Xu Breakdown of academic impact, for papers by Zhongqian Hu Breakdown of academic impact, for papers by Ningyue Yu Breakdown of academic impact, for papers by Jingyu Sun Breakdown of academic impact, for papers by Danli Sheng Breakdown of academic impact, for papers by Xiaoya Zhao Breakdown of academic impact, for papers by Di Jing Breakdown of academic impact, for papers by Ali Tarighatnia
Rankless by CCL
2026